Linda Pape to Atrial Fibrillation
This is a "connection" page, showing publications Linda Pape has written about Atrial Fibrillation.
Connection Strength
0.115
-
Hoppensteadt D, Fareed J, Klein AL, Jasper SE, Apperson-Hansen C, Lieber EA, Katz WE, Malouf JF, Stoddard MF, Pape LA. Comparison of anticoagulant and anti-inflammatory responses using enoxaparin versus unfractionated heparin for transesophageal echocardiography-guided cardioversion of atrial fibrillation. Am J Cardiol. 2008 Oct 01; 102(7):842-6.
Score: 0.043
-
Klein AL, Jasper SE, Katz WE, Malouf JF, Pape LA, Stoddard MF, Apperson-Hansen C, Lieber EA. The use of enoxaparin compared with unfractionated heparin for short-term antithrombotic therapy in atrial fibrillation patients undergoing transoesophageal echocardiography-guided cardioversion: assessment of Cardioversion Using Transoesophageal Echocardiography (ACUTE) II randomized multicentre study. Eur Heart J. 2006 Dec; 27(23):2858-65.
Score: 0.038
-
Jasper SE, Lieber EA, Murray RD, Apperson-Hansen C, Black IW, Grimm RA, Pape LA, Klein AL. Impact of cardioversion strategy on functional capacity in patients with atrial fibrillation: the Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) study. Am Heart J. 2005 Feb; 149(2):309-15.
Score: 0.034